Osaka, Japan

Yoko Fukushima

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoko Fukushima: Innovator in Retinal Vascular Disease Research

Introduction

Yoko Fukushima is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of retinal vascular disease research. Her innovative work has led to the development of a unique transgenic mouse model that closely mimics human retinal vascular diseases.

Latest Patents

Yoko Fukushima holds a patent for a transgenic mouse model of retinal vascular disease, which includes methods for making and using this model. This non-human model animal is designed to exhibit symptoms similar to those of human retinal vascular diseases, such as diabetic retinopathy. The patent outlines methods for producing this model and emphasizes its utility in establishing treatments, prevention strategies, and diagnostic methods for retinal edema, a condition that severely impairs vision. Additionally, the patent provides a method for screening drugs aimed at treating and preventing retinal vascular diseases.

Career Highlights

Yoko Fukushima is affiliated with Osaka University, where she conducts her research. Her work has garnered attention for its potential impact on understanding and treating retinal vascular diseases. With her innovative approach, she has positioned herself as a key figure in this specialized area of medical research.

Collaborations

Yoko has collaborated with notable colleagues, including Kohji Nishida and Toru Nakano. These partnerships have further enhanced her research efforts and contributed to advancements in the field.

Conclusion

Yoko Fukushima's contributions to retinal vascular disease research through her innovative patent and collaborative efforts highlight her role as a leading inventor in this critical area of study. Her work continues to pave the way for future advancements in treatment and prevention strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…